Environmental and Facilities Services

HYGIEIA GROUP

HYGIEIA GROUP released FY2025 Q3 earnings on March 30 (BJT), actual revenue HKD 124.62 M, actual EPS HKD 0.0008

HYGIEIA GROUP released FY2025 9 Months earnings on March 30 (BJT), actual revenue HKD 359.71 M, actual EPS HKD 0.007

HYGIEIA GROUP released FY2025 Q4 earnings on March 30 During-Market (BJT), actual revenue HKD 125.12 M, actual EPS HKD 0.0008

HYGIEIA GROUP released FY2025 earnings on March 30 During-Market (BJT), actual revenue HKD 485.25 M, actual EPS HKD 0.0078

HYGIEIA GROUP to Release FY2025 Earnings Report on March 30 During-Market BJT

HYGIEIA GROUP released FY2025 Q1 earnings on August 28 (BJT), actual revenue HKD 114.09 M, actual EPS HKD 0.003

HYGIEIA GROUP released FY2025 Q2 earnings on August 28 During-Market (BJT), actual revenue HKD 121 M, actual EPS HKD 0.0031

HYGIEIA GROUP released FY2025 Semi-Annual Earnings on August 28 During-Market BJT, actual revenue HKD 235.09 M, actual EPS HKD 0.0062

HYGIEIA GROUP to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

HYGIEIA GROUP Announces Final Dividend Distribution

Hygieia Group Ltd. Holds Annual General Meeting

HYGIEIA GROUP released FY2024 9 Months Earnings on March 28 (BJT), with actual revenue of 328.24 M HKD and EPS of 0.0026 HKD

HYGIEIA GROUP released FY2024 Q3 earnings on March 28 (BJT), actual revenue 114.46 M HKD, actual EPS -0.0005 HKD

HYGIEIA GROUP released FY2024 Q4 earnings on March 28 After-Market (BJT), actual revenue 107.63 M HKD, actual EPS -0.0004 HKD

HYGIEIA GROUP released FY2024 annual earnings on March 28 After-Market (BJT), actual revenue 435.43 M HKD, actual EPS 0.0022 HKD

HYGIEIA GROUP to Release FY2024 Earnings on March 28 After-Market BJT

HYGIEIA GROUP's Acquisition Agreement for 51% Stake in Dongxing Life Convenience Store Worth HKD 34.2 Million Becomes Invalid

HYGIEIA GROUP Releases Interim Results for 2024

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

Ordinary dividend (cash)

Ex Date: 2026.05.26, Cash dividend 0.006 HKD

01650

512580

Hygieia Group Limited (HK:1650) has announced a final cash dividend of SGD 0.001 per share for the financial year ending 31 December 2025, pending shareholder approval on 21 May 2026. Key dates include the ex-dividend date on 26 May 2026, book closure from 28 to 29 May 2026, and payment scheduled for 17 June 2026. The announcement also includes proposed mandates for share issuance and buybacks, re-election of directors, and auditor re-appointment, emphasizing the company's commitment to capital management and governance.

Tip Ranks

GF China Security Environmental Protection Industry ETF

Hygieia Group Sets Final Dividend and AGM Mandates for 2025 Financial Year

163409

159639

Hygieia Group Limited clarified that its proposed final dividend for 2025 is denominated in Singapore dollars, correcting an omission from its annual results announcement. The final dividend is set at 0.001 per share, down from 0.002 per share the previous year. The company emphasized that all other information remains unchanged, aiming to eliminate ambiguity for shareholders. The latest analyst rating for Hygieia Group Limited (HK:1650) is a Buy, with a price target of HK$0.14.

Aegon-Industrial Green Investment Hybrid Fund(LOF)

China Southern CSI SEEE CARBON NEUTRAL ETF

Hygieia Clarifies Singapore-Dollar Denomination of 2025 Final Dividend

HYGIEIA GROUP announced its 2025 annual performance, with revenue of SGD 80.67 million, an increase of 8% year-on-year. It recorded a net profit of SGD 2.67 million, a growth of 252.6%, with earnings per share of 0.13 cents. The final dividend is set at 0.1 cents

AASTOCKS

"Performance" HYGIEIA GROUP's annual net profit increased 2.5 times to SGD 2.67 million, with a final dividend of 0.1 Singapore cents

Hygieia Group Proposes Final Dividend for 2025 With Key Dates Pending

Hygieia Group Proposes Final Dividend for 2025 With Key Dates Pending

Hygieia Group Sets March 30 Board Meeting for 2025 Results and Dividend Review

Hygieia Group Sets March 30 Board Meeting for 2025 Results and Dividend Review

513700

Insilico Medicine and Hygtia Therapeutics, a start-up supported by the Shenzhen Pengfu Fund of Fosun Health Capital and Fosun Pharma, have recently formed an exclusive partnership to further develop ISM8969 on a global scale. This collaboration involves a shared 50% ownership of worldwide rights between the two companies.

Unusual Whales

Penghua CSI HK Connect Health Care Composite ETF

VG Health

iShares US Pharma

Hoth Therapeutics

E Fund CSI 300 Health Care ETF

ChinaAMC CSI All Share Health Care Devices ETF

iShares Biotechnology ETF

Bosera Hang Seng Health Care ETF(QDII)

Invesco Biotechnology & Genome ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

ChinaAMC CSI Biotechnology Theme ETF

Huaan Hang Seng Biotech ETF

Minsheng Royal CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

Invesco Nasdaq Biotechnology ETF

E Fund Hang Seng SCHK Innovative Drug ETF

First Trust NYSE Arca Biotech Index Fd

Penghua SSE STAR Biology and Medicine ETF

Dacheng CSI All Share Health Care Equipment and Services ETF

SPDR S&P Health

Tianhong CNI BIOMEDICINE ETF

iShares Global Healthcare

ChinaAMC SSE STAR Biology and Medicine ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Proshares Ultra Nasdaq Biotech

E Fund CSI Biotechnology Theme ETF

SPDR S&P Biotech

ChinaAMC SSE Health Care ETF Initiating Fund

Ping An CSI Medicine and Medical Device Innovation ETF

FOSUN PHARMA

China Southern Hang Seng Biotech ETF(QDII)

Ark Genomic Revolution ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

VanEck Biotech ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Yinhua CSI Innovative Drugs Industry ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

Health Care Select Sector SPDR

ALPS Medical Breakthrough

Guotai CSI Bio-medicine ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

Insilico Medicine and Hygtia Therapeutics collaborate on ISM8969 for CNS diseases, sharing 50% rights globally.

Hygieia Group Limited (HKG:1650) has reported strong earnings, but its stock performance has been lackluster due to underlying concerns. The company has a negative accrual ratio of -0.39, indicating that its free cash flow significantly exceeds its reported profit. However, its profit was inflated by unusual items totaling S$1.6m, raising questions about sustainability. While the cash conversion appears solid, the reliance on unusual items complicates the assessment of true profitability. Investors should be cautious and consider potential risks before investing in Hygieia Group.

Simplywall

Hygieia Group's (HKG:1650) Performance Is Even Better Than Its Earnings Suggest

HYGIEIA GROUP announced its interim results for the period ending June 30, 2025, with revenue of SGD 39.351 million, a year-on-year increase of 6.4%; profit attributable to shareholders was SGD 2.082 million, a year-on-year increase of 90.66%; earnings per share were 0.104 Singapore cents. The revenue growth was primarily driven by new large projects in Singapore and organic growth in environmental services in Thailand

Zhitong

HYGIEIA GROUP released its interim results, with shareholders' profit attributable to shareholders reaching SGD 2.082 million, an increase of 90.66% year-on-year

HYGIEIA GROUP(01650.HK)

Hygieia Group Sets Final Dividend and AGM Mandates for 2025 Financial Year

Hygieia Clarifies Singapore-Dollar Denomination of 2025 Final Dividend

"Performance" HYGIEIA GROUP's annual net profit increased 2.5 times to SGD 2.67 million, with a final dividend of 0.1 Singapore cents

Hygieia Group Proposes Final Dividend for 2025 With Key Dates Pending

Hygieia Group Sets March 30 Board Meeting for 2025 Results and Dividend Review

Insilico Medicine and Hygtia Therapeutics collaborate on ISM8969 for CNS diseases, sharing 50% rights globally.

Hygieia Group's (HKG:1650) Performance Is Even Better Than Its Earnings Suggest

HYGIEIA GROUP released its interim results, with shareholders' profit attributable to shareholders reaching SGD 2.082 million, an increase of 90.66% year-on-year

Trending